Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Higher Doses of Botulinum Toxin for Gummy Smile
NCT05127018Phase 2Completed
- Sponsor
- Peking University
- Start
- Nov 2019
- Primary completion
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of botulinum toxin type A in excessive gingival display (2 arms), sponsored by Peking University. Primary endpoint: Anterior Gingival Exposure. Started Nov 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
excessive gingival display
Beyond the preview
Go deeper on NCT05127018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05127018.